nach oben

Erschienen in:

01.03.2014 | Research Article

Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma

verfasst von: Norberto A. Gandini, María E. Fermento, Débora G. Salomón, Diego J. Obiol, Nancy C. Andrés, Jean C. Zenklusen, Julián Arevalo, Jorge Blasco, Alejandro López Romero, María M. Facchinetti, Alejandro C. Curino

Erschienen in: Tumor Biology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

In human glioma tumors, heme oxygenase-1 (HO-1) has been shown to be upregulated both when compared with normal brain tissues and also during oligodendroglioma progression. The cell types that express HO-1 have been shown to be mainly macrophages/microglia and T cells. However, many other reports also demonstrated that cell lines derived from glioma tumors and astrocytes express HO-1 after the occurrence of a wide variety of cell injuries and stressors. In addition, the significance of HO-1 upregulation in glioma had not, so far, been addressed. We therefore aimed at investigating the expression and significance of HO-1 in human glial tumors. For this purpose, we performed a wide screening of HO-1 expression in gliomas by using tissue microarrays containing astrocytomas, oligodendrogliomas, mixed tumors, and normal brain tissues. We subsequently correlated protein expression with patient clinicopathological data. We found differences in HO-1 positivity rates between non-malignant brain (22 %) and gliomas (54 %, p = 0.01). HO-1 was expressed by tumor cells and showed cytoplasmic localization, although 19 % of tumor samples also depicted nuclear staining. Importantly, a significant decrease in the overall survival time of grade II and III astrocytoma patients with HO-1 expression was observed. This result was validated at the mRNA level in a cohort of 105 samples. However, no association of HO-1 nuclear localization with patient survival was detected. In vitro experiments aimed at investigating the role of HO-1 in glioma progression showed that HO-1 modulates glioma cell proliferation, but has no effects on cellular migration. In conclusion, our results corroborate the higher frequency of HO-1 protein expression in gliomas than in normal brain, demonstrate that HO-1 is expressed by glial malignant cells, and show an association of HO-1 expression with patients’ shorter survival time.

Nur mit Berechtigung zugänglich

Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70:217–28.PubMedCrossRef

Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, Aquilanti E, et al. Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer Res. 2009;69:1596–603.PubMedCrossRefPubMedCentral

Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 2003;22:4918–23.PubMedCrossRef

Ohgaki H. Genetic pathways to glioblastomas. Neuropathology. 2005;25:1–7.PubMedCrossRef

Li A, Bozdag S, Kotliarov Y, Fine HA. GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak. 2010;10:38. doi:10.1186/1472-6947-10-38.PubMedCrossRefPubMedCentral

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol. 2007;114:97–109.PubMedCrossRefPubMedCentral

Ware ML, Berger MS, Binder DK. Molecular biology of glioma tumorigenesis. Histol Histopathol. 2003;18:207–16.PubMed

Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med. 2004;82:656–70.PubMedCrossRef

Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10:319–31.PubMedCrossRef

10.

Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, et al. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst. 2005;97:880–7.PubMedCrossRef

11.

Raizer JJ. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. J Neurooncol. 2005;74:77–86.PubMedCrossRef

12.

Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61:748–55.PubMedCrossRefPubMedCentral

13.

De Matteis F, Dawson SJ, Pons N, Pipino S. Bilirubin and uroporphyrinogen oxidation by induced cytochrome P4501A and cytochrome P4502B. Role of polyhalogenated biphenyls of different configuration. Biochem Pharmacol. 2002;63:615–24.PubMedCrossRef

14.

Jozkowicz A, Was H, Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal. 2007;9:2099–117.PubMedCrossRefPubMedCentral

15.

Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422–8.PubMedCrossRef

16.

Snyder SH, Barañano DE. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology. 2001;25:294–8.PubMedCrossRef

17.

Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem Biophys Res Commun. 2005;338:568–77.PubMedCrossRef

18.

Was H, Dulak J, Jozkowickz A. Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets. 2010;11:1551–70.PubMedCrossRef

19.

Dwyer BE, Nishimura RN, Lu SY. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res Mol Brain Res. 1995;30:37–47.PubMedCrossRef

20.

Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med. 2004;37:1995–2011.PubMedCrossRef

21.

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.PubMedCrossRef

22.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.PubMedCrossRef

23.

Gandini NA, Fermento ME, Salomón DG, Blasco J, Patel V, Gutkind JS, et al. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp Mol Pathol. 2012;93:237–45.PubMedCrossRef

24.

Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Molinolo A, Hewitt SM, et al. Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer. 2012;77:168–75.PubMedCrossRef

25.

Hara E, Takahashi K, Tominaga T, Kumabe T, Kayama T, Suzuki H, et al. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem Biophys Res Commun. 1996;224:153–8.PubMedCrossRef

26.

Deininger MH, Meyermann R, Trautmann K, Duffner F, Grote EH, Wickboldt J, et al. Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulates during oligodendroglioma progression. Brain Res. 2000;882:1–8.PubMedCrossRef

27.

El Andaloussi A, Lesniak MS. CD4⁺CD25⁺FoxP3⁺ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J Neurooncol. 2007;83:145–52.PubMedCrossRef

28.

Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999;5:1107–13.PubMed

29.

Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007;282:20621–33.PubMedCrossRef

30.

Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, et al. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer. 2007;97:1683–9.PubMedCrossRefPubMedCentral

31.

Tibullo D, Barbagallo I, Giallongo C, La Cava P, Parrinello N, Vanella L, et al. Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells. Curr Pharm Des. 2013;19:2765–70.PubMedCrossRef

32.

Li Volti G, Ientile R, Abraham NG, Vanella A, Cannavò G, Mazza F, et al. Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell culture during differentiation: effect of glutamate. Biochem Biophys Res Commun. 2004;315:517–24.PubMedCrossRef

33.

Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res. 2009;7:157–67.PubMedCrossRefPubMedCentral

34.

Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg. 2002;87:13–5.PubMed

35.

Facchinetti MM, Gandini NA, Fermento ME, Sterin-Speziale NB, Ji Y, Vyomesh Patel J, et al. The expression of sphingosine kinase-1 in head and neck carcinoma. Cells Tissues Organs. 2010;192:314–24.PubMedCrossRefPubMedCentral

36.

Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol. 2007;60(10):1112–6.PubMedCrossRefPubMedCentral

37.

Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol. 2000;148:957–70.PubMedCrossRefPubMedCentral

38.

Schacter BA, Kurz P. Alterations in hepatic and splenic microsomal electron transport system components, drug metabolism, heme oxygenase activity, and cytochrome P-450 turnover in Murphy–Sturm lymphosarcoma-bearing rats. Cancer Res. 1982;42:3557–64.PubMed

39.

Maines MD, Abrahamsson PA. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology. 1996;47:727–33.PubMedCrossRef

40.

Goodman AI, Choudhury M, daSilva JL, Schwartzman ML, Abraham NG. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc for Exp Biol Med. 1997;214:54–61.CrossRef

41.

Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, et al. Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumors and implications for tumor growth. Br J Cancer. 1999;80:1945–54.PubMedCrossRefPubMedCentral

42.

Torisu-Itakura H, Furue M, Kuwano M, Ono M. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res. 2000;91:906–10.PubMedCrossRef

43.

McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, et al. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood. 2004;103:3465–73.PubMedCrossRef

44.

Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res. 2005;11:3790–8.PubMedCrossRef

45.

Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, et al. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 2004;64:3148–54.PubMedCrossRef

46.

Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, et al. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer. 2004;91:1551–5.PubMedCrossRefPubMedCentral

47.

Lee J, Lee SK, Lee BU, Lee HJ, Cho NP, Yoon JH, et al. Upregulation of heme oxygenase-1 in oral epithelial dysplasias. Int J Oral Maxillofac Surg. 2008;37:287–92.PubMedCrossRef

48.

Lee SS, Yang SF, Tsai CH, Chou MC, Chou MY, Chang YC. Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. J Formos Med Assoc. 2008;107:355–63.PubMedCrossRef

49.

Liu Y, Liang Y, Zheng T, Yang G, Zhang X, Sun Z, et al. Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells. J Neurooncol. 2011;104:449–58.PubMedCrossRef

50.

Chen CH, Chang YJ, Ku MS, Chung KT, Yang JT. Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation. J Mol Med (Berl). 2011;89:303–15.PubMedCrossRef

51.

Long J, Manchandia T, Ban K, Gao S, Miller C, Chandra J. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1. Cancer Chemother Pharmacol. 2007;59:527–635.PubMedCrossRef

52.

Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009;10:65.PubMedCrossRefPubMedCentral

53.

Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, et al. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009;7:1745–55. doi:10.1158/1541-7786.MCR-08-0325.PubMedCrossRef

54.

Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, et al. Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis. 2011;14(4):467–79.PubMedCrossRef

55.

Miyake M, Fujimoto K, Anai S, Ohnishi S, Nakai Y, Inoue T, et al. Clinical significance of heme oxygenase-1 expression in non-muscle-invasive bladder cancer. Urol Int. 2010;85:355–63. doi:10.1159/000317785.PubMedCrossRef

56.

Yim MS, Ha YS, Kim IY, Yun SJ, Choi YH, Kim WJ. HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression. J Urol. 2011;185:701–5.PubMedCrossRef

57.

Tsai JR, Wang HM, Liu PL, Chen YH, Yang MC, Chou SH, et al. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncol (Dordr). 2012;35:461–71.PubMedCrossRef

58.

Yanagawa T, Omura K, Harada H, Nakaso K, Iwasa S, Koyama Y, et al. Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral Oncol. 2004;40:21–7.PubMedCrossRef

59.

Becker JC, Fukui H, Imai Y, Sekikawa A, Kimura T, Yamagishi H, et al. Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand J Gastroenterol. 2007;42:852–8.PubMedCrossRef

60.

Li Y, Su J, DingZhang X, Zhang J, Yoshimoto M, Liu S, et al. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome. J Pathol. 2011;224:90–100. doi:10.1002/path.2855.PubMedCrossRef

61.

Al-Owais MM, Scragg JL, Dallas ML, Boycott HE, Warburton P, Chakrabarty A, et al. Carbon monoxide mediates the anti-apoptotic effects of heme oxygenase-1 in medulloblastoma DAOY cells via K⁺ channel inhibition. J Biol Chem. 2012;287:24754–64. doi:10.1074/jbc.M112.357012.PubMedCrossRefPubMedCentral

62.

Lu TH, Pepe JA, Gildemeister OS, Tyrrell RM, Bonkovsky HL. Regulation of expression of the human heme oxygenase-1 gene in transfected chick embryo liver cell cultures. Biochim Biophys Acta. 1997;1352:293–302.PubMedCrossRef

63.

Pan HC, Yang CN, Hung YW, Lee WJ, Tien HR, Shen CC, et al. Reciprocal modulation of C/EBPα and C/EBPβ by IL-13 in activated microglia prevents neuronal death. Eur J Immunol. 2013. doi:10.1002/eji.201343301.

64.

Birrane G, Li H, Yang S, Tachado SD, Seng S. Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion. Int J Oncol. 2013;42:1919–28. doi:10.3892/ijo.2013.1910.PubMedPubMedCentral

Titel: Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma
verfasst von: Norberto A. Gandini
María E. Fermento
Débora G. Salomón
Diego J. Obiol
Nancy C. Andrés
Jean C. Zenklusen
Julián Arevalo
Jorge Blasco
Alejandro López Romero
María M. Facchinetti
Alejandro C. Curino
Publikationsdatum: 01.03.2014
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 3/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1373-z

Neu im Fachgebiet Onkologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Springer Medizin

Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma

Abstract

Neu im Fachgebiet Onkologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case–control study and meta-analysis

Mutation and protein expression analysis of CYP1A1 gene—a study on female breast cancer cases from India

Astrocyte elevated gene-1 is a novel biomarker of epithelial–mesenchymal transition and progression of hepatocellular carcinoma in two China regions

Increased SPHK1 expression is associated with poor prognosis in bladder cancer

FAS−1377 A/G polymorphism in breast cancer: a meta-analysis

Clinical implications of GRHL3 protein expression in breast cancer

Neu im Fachgebiet Onkologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Update Onkologie